#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Kearns-Sayre syndrome Ductal adenocarcinoma of pancreas Mantle cell lymphoma refractory Hereditary neuropathic amyloidosis Pustular psoriasis Chondrosarcoma Ichthyosis Non-small cell lung cancer recurrent Burkitt's lymphoma refractory Advanced systemic mastocytosis Pleural mesothelioma malignant Squamous cell carcinoma of the vulva Marginal zone lymphoma recurrent Renal cancer metastatic Vulval cancer recurrent More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis II – Diagnostics Factor VIII deficiency – Life with Disease Angiosarcoma – Basic Information Idiopathic inflammatory myopathy Erdheim-Chester disease – Basic Information Glomerulonephritis membranoproliferative – Treatment Waldenstrom’s macroglobulinaemia Haemophilia B with anti factor IX – Basic Information KBG syndrome – Treatment Pituitary-dependent Cushing’s syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Hydralazine Hydrochloride Tremelimumab Ticagrelor FOSFOMYCIN CALCIUM Teropavimab Dacarbazine Nandrolone Decanoate CHONDROITIN SULFATE SODIUM Alxn1850 Glucocorticoids Lonapegsomatropin Mirtazapine Tegafur Levamlodipine Succinate Cortisone Panobinostat Ixekizumab Ranolazine Fluorodopa (18F) Oxygen Ph.eur. More therapies…

    Learn about Your Condition

    Endocarditis Fungal infection Acute on chronic liver failure Breast cancer stage II Underweight Lower limb fracture Acute promyelocytic leukaemia Hand dermatitis Pigmentary glaucoma Eye disorder Hyperglycaemia Corneal graft rejection Trigeminal neuralgia Fabry's disease Ewing's sarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Universitaire Rouen

Centre Hospitalier Universitaire Rouen

1 Rue De Germont, Rouen, 76000, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study of rituximab and glucocorticoids versus placebo and glucocorticoids in adults with newly diagnosed or relapsing IgA vasculitis

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    • Henoch-Schonlein purpura
    Investigated Drugs:
    • Rituximab
    France
  • Study on Severe Erythema Multiforme: Comparing Methylprednisolone Acetate and Lidocaine Hydrochloride Monohydrate with Placebo for Hospitalized Patients

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Erythema multiforme
    Investigated Drugs:
    • Lidocaine Hydrochloride Monohydrate
    • Methylprednisolone Acetate
    • Prednisone
    France
  • Study of INCB099280 for Patients With Advanced Cutaneous Squamous Cell Carcinoma Not Suitable for Surgery or Radiotherapy

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Skin squamous cell carcinoma metastatic
    • Skin squamous cell carcinoma recurrent
    Investigated Drugs:
    • Incb099280
    Croatia Finland France Hungary The Netherlands Romania +1
  • Study on the Effectiveness of JNJ-77242113 and Deucravacitinib for Treating Moderate to Severe Plaque Psoriasis in Adults

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Jnj-77242113
    • Deucravacitinib
    France Germany Hungary Italy Poland Spain
  • Study on BIIB080 for Patients Aged 50-80 with Mild Cognitive Impairment or Mild Alzheimer’s Disease Dementia

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • 6-(Fluoro-18F)-3-(1H-Pyrrolo[2,3-C]Pyridin-1-Yl)-5-Isoquinolinamine
    • Florbetaben (18F)
    • Flutemetamol (18F)
    Belgium Czechia Denmark Finland France Germany +5
  • Study on Doravirine and Islatravir for People with HIV-1 Previously Treated with the Same Drug Combination

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Doravirine
    • Islatravir
    Finland France Germany Italy Poland Spain
  • Study on Joint Health in Hemophilia A and B Patients Using Efmoroctocog Alfa or Eftrenonacog Alfa

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Factor IX deficiency
    • Factor VIII deficiency
    Investigated Drugs:
    • Efmoroctocog Alfa
    • Eftrenonacog Alfa
    Bulgaria Croatia Czechia France Hungary Ireland +4
  • Study on Pegaspargase for Treating Acute Lymphoblastic Leukemia in Children and Adolescents

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Pegaspargase
    France
  • Study on Spironolactone for Maintaining Sinus Rhythm in Hypertensive Patients with Atrial Fibrillation and Preserved Heart Function

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Micronised Spironolactone
    France
  • Study on Apremilast for Patients with Severe Recurrent Mouth Ulcers Resistant to Colchicine

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Stomatitis
    Investigated Drugs:
    • Apremilast
    France
Previous Page
1 … 25 26 27 28 29 … 48
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!